Journal
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
Volume 62, Issue 10, Pages 788-794Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/JOM.0000000000001915
Keywords
manganese; positron emission tomography; parkinsonism; vesicular monoamine transporter 2
Categories
Funding
- NIH [R01ES021488, K23ES021444, K24ES017765, R01ES013743, R01ES021488-02S1, P42ES004696, R01ES029524]
- American Parkinson's Disease Association
Ask authors/readers for more resources
Objective: To understand the neurotoxic effects of manganese (Mn) exposure on monoaminergic function, utilizing [C-11]dihydrotetrabenazine (DTBZ) positron emission tomography (PET) to measure vesicular monoamine transporter 2 (VMAT2). Methods: Basal ganglia and thalamic DTBZ binding potentials (BPND) were calculated on 56 PETs from 41 Mn-exposed workers. Associations between cumulative Mn exposure, regional BPND, and parkinsonism were examined by mixed linear regression. Results: Thalamic DTBZ BPND was inversely associated with exposure in workers with less than 3 mg Mn/m(3)-yrs, but subsequently remained stable. Pallidal DTBZ binding increased in workers with less than 2 mg Mn/m(3)-yrs of exposure, but decreased thereafter. Thalamic DTBZ binding was inversely associated with parkinsonism (P = 0.003). Conclusion: Mn-dose-dependent associations with thalamic and pallidal DTBZ binding indicate direct effects on monoaminergic VMAT2. Thalamic DTBZ binding was also associated with parkinsonism, suggesting potential as an early biomarker of Mn neurotoxicity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available